Nyxoah’s Genio® Wins Prix Galien UK 2026 Award for Best Medical Technology
Mont-Saint-Guibert, Belgium – June 15, 2026, 10:05 pm CET / 04:05 pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on developing innovative solutions for Obstructive Sleep Apnea (OSA), today announced that Genio®, its hypoglossal nerve stimulation therapy for OSA, was awarded the Prix Galien UK 2026 […]